These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35983036)

  • 21. The tumour microenvironment and immune milieu of cholangiocarcinoma.
    Fabris L; Perugorria MJ; Mertens J; Björkström NK; Cramer T; Lleo A; Solinas A; Sänger H; Lukacs-Kornek V; Moncsek A; Siebenhüner A; Strazzabosco M
    Liver Int; 2019 May; 39 Suppl 1(Suppl 1):63-78. PubMed ID: 30907492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?
    Wang J; Loeuillard E; Gores GJ; Ilyas SI
    Expert Opin Ther Targets; 2021 Oct; 25(10):835-845. PubMed ID: 34806500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated fibroblasts in cholangiocarcinoma.
    Vaquero J; Aoudjehane L; Fouassier L
    Curr Opin Gastroenterol; 2020 Mar; 36(2):63-69. PubMed ID: 31934895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
    Liu D; Heij LR; Czigany Z; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):127. PubMed ID: 35392957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
    Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
    Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.
    Cadamuro M; Stecca T; Brivio S; Mariotti V; Fiorotto R; Spirli C; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1435-1443. PubMed ID: 28757170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma.
    Job S; Rapoud D; Dos Santos A; Gonzalez P; Desterke C; Pascal G; Elarouci N; Ayadi M; Adam R; Azoulay D; Castaing D; Vibert E; Cherqui D; Samuel D; Sa Cuhna A; Marchio A; Pineau P; Guettier C; de Reyniès A; Faivre J
    Hepatology; 2020 Sep; 72(3):965-981. PubMed ID: 31875970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of MRI 3D-VIBE systems applied to preoperative estimate of hepatic portal cholangiocarcinoma].
    Yin LL; Song B; Li YC; Chen X; Li CX; Zhong KX; Sun JY; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):928-33. PubMed ID: 17236597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.
    Gentilini A; Pastore M; Marra F; Raggi C
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling.
    Lobe C; Vallette M; Arbelaiz A; Gonzalez-Sanchez E; Izquierdo L; Pellat A; Guedj N; Louis C; Paradis V; Banales JM; Coulouarn C; Housset C; Vaquero J; Fouassier L
    Hepatology; 2021 Dec; 74(6):3194-3212. PubMed ID: 34297412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
    Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studying Tumor Angiogenesis and Cancer Invasion in a Three-Dimensional Vascularized Breast Cancer Micro-Environment.
    Dey M; Ayan B; Yurieva M; Unutmaz D; Ozbolat IT
    Adv Biol (Weinh); 2021 Jul; 5(7):e2100090. PubMed ID: 33857356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine.
    Germain N; Dhayer M; Dekiouk S; Marchetti P
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Component with abundant immune-related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis.
    Yagi N; Suzuki T; Mizuno S; Kojima M; Kudo M; Sugimoto M; Kobayashi S; Gotohda N; Ishii G; Nakatsura T
    Cancer Sci; 2022 May; 113(5):1564-1574. PubMed ID: 35226764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 3D-Bioprinted Multiple Myeloma Model.
    Wu D; Wang Z; Li J; Song Y; Perez MEM; Wang Z; Cao X; Cao C; Maharjan S; Anderson KC; Chauhan D; Zhang YS
    Adv Healthc Mater; 2022 Apr; 11(7):e2100884. PubMed ID: 34558232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.
    Zhang Q; Lou Y; Bai XL; Liang TB
    World J Gastroenterol; 2018 Aug; 24(31):3500-3512. PubMed ID: 30131656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy.
    Sato Y; Tanaka S; Kinoshita M; Takemura S; Shinkawa H; Kokudo T; Hasegawa K; Tanaka H; Yoshimoto H; Mori A; Yamamura M; Sasaki M; Harada K; Kubo S
    J Hepatobiliary Pancreat Sci; 2020 Nov; 27(11):860-869. PubMed ID: 32506715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D Bioprinting and Stem Cells.
    Moore CA; Shah NN; Smith CP; Rameshwar P
    Methods Mol Biol; 2018; 1842():93-103. PubMed ID: 30196404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.